41 Neuropsychiatric symptoms of COVID-19 may develop due to damage to brain tissue caused by these mini-strokes or microbleeds
Secretion, degradation, and elimination of glucagon-like peptide 1 (GLP-1) and gastric inhibitory polypeptide (GIP) in patients with chronic renal insufficiency and healthy controls
Key Factors Determining Treatment Duration Determining how long you should take GLP-1 drugs depends on a blend of medical necessity, side effect management, and lifestyle factors
Ongoing safety data supports GLP-1 use for extended periods, with many patients benefiting from 2+ years of continuous therapy without serious adverse effects
In general, our results showed that ethanol exposure may reduce the antioxidant capacity in the hippocampal of WT mice, leading to the occurrence of neuroinflammation, while in APP/PS1 mice, ethanol exposure further worsened this process by exacerbating the pathological progression of AD